Post-Approval Trial of the Talent™ Abdominal Stent Graft to Treat Aortic Aneurysms (VITALITY)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine, through the endpoints established in this protocol, the long-term safety and effectiveness of the Talent Abdominal Stent Graft System, in a post-approval environment.
| Condition | Intervention | Phase |
|---|---|---|
|
Aortic Aneurysm, Abdominal |
Device: Talent Abdominal Stent Graft |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Endovascular Repair Using the Talent™ Abdominal Stent Graft System in Abdominal Aortic Aneurysms (VITALITY) |
- Aneurysm-related Mortality (ARM) [ Time Frame: 5 year KM ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 94 |
| Study Start Date: | December 2008 |
| Estimated Study Completion Date: | June 2015 |
| Estimated Primary Completion Date: | June 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Treatment
Patients diagnosed with an abdominal aortic or aorto-iliac aneurysm that are considered candidates for endovascular repair, per the FDA approved IFU.
|
Device: Talent Abdominal Stent Graft
The Talent Abdominal Stent Graft is indicated for the endovascular treatment of abdominal aortic aneurysms with or without iliac involvement.
|
Detailed Description:
The Talent Abdominal Stent Graft System is a next-generation modular system for endovascular repair of AAA. The system was designed with the following enhancements: a suprarenal wire frame to provide migration resistance, and improved flexibility designed to treat difficult anatomies.
Medtronic Vascular submitted a Pre-Market Application (PMA) to the FDA on October 17, 2007, and received market approval for the Talent Abdominal Stent Graft System on April 15th, 2008. As a condition of approval, the FDA has requested a post-approval study. Medtronic has therefore designed a post-approval study, in collaboration with FDA, to document the performance of the Talent Abdominal Stent Graft System under market conditions.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Subject must have an abdominal aortic aneurysm, with or without iliac involvement.
- Iliac/femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;
- A proximal aortic neck length of ≥ 10mm;
- Proximal aortic neck angulation ≤ 60°;
- Distal iliac artery fixation length of ≥ 15mm;
- An aortic neck diameter of 18-32mm and iliac artery diameters of 8-22mm; and
- Vessel morphology suitable for endovascular repair.
Exclusion Criteria:
- Are less than 18 years of age
- Are pregnant or lactating
- Have a dominant patent inferior mesenteric artery and an occluded or stenotic celiac and/or superior mesenteric artery
- Have aneurysmal involvement or occlusion (surgically performed or naturally occurring) of the bilateral internal iliac arteries
- Have vessels and/or aneurysm dimensions that cannot accommodate the Talent Abdominal Stent Graft as per the indications in Section 3.
- Have no distal vascular bed (one vessel lower extremity run-off required)
- Have contraindications for use of contrast medium or anticoagulation drugs
- Have an uncorrectable coagulopathy
- Have an SVS/AAVS score greater than 2
- Have a mycotic aneurysm
- Have circumferential mural thrombus in the proximal aortic neck
- Have had a recent (within 3 months) myocardial infarction (MI), cerebral vascular accident (CVA), or major surgical intervention
- Have traumatic aortic injury
- Have leaking, pending rupture or ruptured aneurysms
- Have pseudoaneurysms resulting from previous graft placement
- Require a revision to previously placed endovascular stent grafts.
- Have genetic connective tissue disease (e.g., Marfan's or Ehlers-Danlos' Syndromes)
- Have concomitant thoracic aortic or thoracoabdominal aneurysms
- Are patients with active systemic infections
- Are patients who have a condition that threatens to infect the graft.
- Are patients with sensitivities or allergies to the device materials.
- Have access vessels (as determined by treating physician) that preclude safe insertion of the delivery system. NOTE: Iliac conduits may be used to ensure the safe insertion of the delivery system.
Contacts and Locations| United States, California | |
| USC Univerisity Hospital | |
| Los Angeles, California, United States, 90033 | |
| Palo Alto VAMC | |
| Palo Alto, California, United States, 94304 | |
| United States, Delaware | |
| Christiana Care Health Services | |
| Newark, Delaware, United States, 19713 | |
| United States, District of Columbia | |
| Washington Hospital Center | |
| Washington, District of Columbia, United States, 20010 | |
| United States, Florida | |
| Mayo Clinic Jacksonville | |
| Jacksonville, Florida, United States, 32224 | |
| United States, Massachusetts | |
| Boston Medical Center | |
| Boston, Massachusetts, United States, 02118 | |
| United States, Missouri | |
| St. John's Medical Research Institute | |
| Springfield, Missouri, United States, 65810 | |
| Barnes Jewish | |
| St Louis, Missouri, United States, 63110 | |
| United States, North Carolina | |
| East Carolina University | |
| Greenville, North Carolina, United States, 27834 | |
| Forsyth Medical Center | |
| Winston Salem, North Carolina, United States, 27103 | |
| United States, Pennsylvania | |
| Lehigh Valley Hospital | |
| Allentown, Pennsylvania, United States, 18103 | |
| Pinnacle Health Network | |
| Harrisburg, Pennsylvania, United States, 17110 | |
| United States, South Dakota | |
| North Central Heart Institute | |
| Sioux Falls, South Dakota, United States, 57108 | |
| Sanford USD Medical Center | |
| Sioux Falls, South Dakota, United States, 57104 | |
| United States, Tennessee | |
| St. Mary's Medical Center | |
| Knoxville, Tennessee, United States, 37923 | |
| Vanderbilt Vascular Surgery | |
| Nashville, Tennessee, United States, 37232 | |
| United States, Texas | |
| Methodist Dallas Medical Center | |
| Dallas, Texas, United States, 75208 | |
| Wilford Hall Medical Center | |
| Lackland AFB, Texas, United States, 78236 | |
| United States, Virginia | |
| Inova Fairfax Hospital | |
| Falls Church, Virginia, United States, 22042 | |
| United States, West Virginia | |
| Charleston Area Medical Center | |
| Charleston, West Virginia, United States, 23504 | |
| Principal Investigator: | Luis Sanchez, MD | Washington University in St. Louis |
More Information
Additional Information:
No publications provided
| Responsible Party: | Medtronic Endovascular |
| ClinicalTrials.gov Identifier: | NCT00816062 History of Changes |
| Other Study ID Numbers: | P070027/S002 |
| Study First Received: | December 29, 2008 |
| Last Updated: | January 14, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Medtronic Endovascular:
|
Aortic Aneurysm Aneurysm Abdominal Aortic Aneurysm Talent Medtronic |
Additional relevant MeSH terms:
|
Aneurysm Aortic Aneurysm Aortic Aneurysm, Abdominal |
Vascular Diseases Cardiovascular Diseases Aortic Diseases |
ClinicalTrials.gov processed this record on June 18, 2013